BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Carter EE, Barr SG, Clarke AE. The global burden of SLE: prevalence, health disparities and socioeconomic impact. Nat Rev Rheumatol 2016;12:605-20. [PMID: 27558659 DOI: 10.1038/nrrheum.2016.137] [Cited by in Crossref: 151] [Cited by in F6Publishing: 135] [Article Influence: 25.2] [Reference Citation Analysis]
Number Citing Articles
1 Babaoglu H, Li J, Goldman D, Magder LS, Petri M. Predictors of predominant Lupus Low Disease Activity State (LLDAS-50). Lupus 2019;28:1648-55. [PMID: 31694446 DOI: 10.1177/0961203319886028] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
2 Blair HA, Duggan ST. Belimumab: A Review in Systemic Lupus Erythematosus. Drugs 2018;78:355-66. [PMID: 29396833 DOI: 10.1007/s40265-018-0872-z] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 10.7] [Reference Citation Analysis]
3 Iudici M, Pantano I, Fasano S, Pierro L, Charlier B, Pingeon M, Dal Piaz F, Filippelli A, Izzo V. Health status and concomitant prescription of immunosuppressants are risk factors for hydroxychloroquine non-adherence in systemic lupus patients with prolonged inactive disease. Lupus 2017;27:265-72. [DOI: 10.1177/0961203317717631] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
4 Al-Adhoubi NK, Al-Balushi F, Al Salmi I, Ali M, Al Lawati T, Al Lawati BSH, Abdwani R, Al Shamsi A, Al Kaabi J, Al Mashaani M, Krishna Jha D, Sayed S, Al-Araimi T, Liyanage P, Al Shirawi A, Al Wahshi HA. A multicenter longitudinal study of the prevalence and mortality rate of systemic lupus erythematosus patients in Oman: Oman Lupus Study. Int J Rheum Dis 2021;24:847-54. [PMID: 34058079 DOI: 10.1111/1756-185X.14130] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 Keeling SO, Alabdurubalnabi Z, Avina-Zubieta A, Barr S, Bergeron L, Bernatsky S, Bourre-Tessier J, Clarke A, Baril-Dionne A, Dutz J, Ensworth S, Fifi-Mah A, Fortin PR, Gladman DD, Haaland D, Hanly JG, Hiraki LT, Hussein S, Legault K, Levy D, Lim L, Matsos M, McDonald EG, Medina-Rosas J, Pardo Pardi J, Peschken C, Pineau C, Pope J, Rader T, Reynolds J, Silverman E, Tselios K, Suitner M, Urowitz M, Touma Z, Vinet E, Santesso N. Canadian Rheumatology Association Recommendations for the Assessment and Monitoring of Systemic Lupus Erythematosus. J Rheumatol 2018;45:1426-39. [PMID: 30173152 DOI: 10.3899/jrheum.171459] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
6 Sun J, Lai H, Shen D, Wu P, Yang J, Sun Z, Guo Y. Reduced sB7-H3 Expression in the Peripheral Blood of Systemic Lupus Erythematosus Patients. J Immunol Res 2017;2017:5728512. [PMID: 29423417 DOI: 10.1155/2017/5728512] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
7 Askanase AD, Furie RA. A Narrative Review of Repository Corticotropin Injection for the Treatment of Systemic Lupus Erythematosus. Adv Ther 2022. [PMID: 35641860 DOI: 10.1007/s12325-022-02160-y] [Reference Citation Analysis]
8 Owen KA, Price A, Ainsworth H, Aidukaitis BN, Bachali P, Catalina MD, Dittman JM, Howard TD, Kingsmore KM, Labonte AC, Marion MC, Robl RD, Zimmerman KD, Langefeld CD, Grammer AC, Lipsky PE. Analysis of Trans-Ancestral SLE Risk Loci Identifies Unique Biologic Networks and Drug Targets in African and European Ancestries. Am J Hum Genet 2020;107:864-81. [PMID: 33031749 DOI: 10.1016/j.ajhg.2020.09.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
9 Murimi-Worstell IB, Lin DH, Kan H, Tierce J, Wang X, Nab H, Desta B, Alexander GC, Hammond ER. Healthcare Utilization and Costs of Systemic Lupus Erythematosus by Disease Severity in the United States. J Rheumatol 2021;48:385-93. [PMID: 32611669 DOI: 10.3899/jrheum.191187] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
10 Dall LB, Deleuran B, Østergaard LJ, Mardahl M, Denton PW, Nejsum P. Helminth products modulate innate immune recognition of nucleic acids in systemic lupus erythematosus. Lupus 2022;:9612033221080548. [PMID: 35202548 DOI: 10.1177/09612033221080548] [Reference Citation Analysis]
11 Leong PY, Huang JY, Chiou JY, Bai YC, Wei JC. The prevalence and incidence of systemic lupus erythematosus in Taiwan: a nationwide population-based study. Sci Rep 2021;11:5631. [PMID: 33707552 DOI: 10.1038/s41598-021-84957-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Castro-Villarreal S, Beltran-Ostos A, Valencia CF. Estimation of Prevalence and Incremental Costs of Systemic Lupus Erythematosus in a Middle-Income Country Using Machine Learning on Administrative Health Data. Value Health Reg Issues 2021;26:98-104. [PMID: 34166883 DOI: 10.1016/j.vhri.2021.04.005] [Reference Citation Analysis]
13 Rovsing C, Rovsing H, Liboriussen CH, Jensen MK, Andersen SS, Andersen SS, Kristensen S, Jochumsen M. Deep Breathing Increases Heart Rate Variability in Patients With Rheumatoid Arthritis and Systemic Lupus Erythematosus. J Clin Rheumatol 2021;27:261-6. [PMID: 32195851 DOI: 10.1097/RHU.0000000000001300] [Reference Citation Analysis]
14 Babaoğlu H, Li J, Goldman D, Magder LS, Petri M. Time to Lupus Low Disease Activity State in the Hopkins Lupus Cohort: Role of African American Ethnicity. Arthritis Care Res (Hoboken) 2020;72:225-32. [PMID: 31507071 DOI: 10.1002/acr.24063] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
15 Mehta B, Salmon J, Ibrahim S. Potential Shortages of Hydroxychloroquine for Patients with Lupus During the Coronavirus Disease 2019 Pandemic. JAMA Health Forum 2020;1:e200438. [DOI: 10.1001/jamahealthforum.2020.0438] [Cited by in Crossref: 22] [Cited by in F6Publishing: 6] [Article Influence: 11.0] [Reference Citation Analysis]
16 Falasinnu T, Drenkard C, Bao G, Mackey S, Lim SS. The Problem of Pain in Systemic Lupus Erythematosus: An Explication of the Role of Biopsychosocial Mechanisms. J Rheumatol 2021;48:1279-89. [PMID: 33262298 DOI: 10.3899/jrheum.200595] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Ha E, Bae SC, Kim K. Recent advances in understanding the genetic basis of systemic lupus erythematosus. Semin Immunopathol 2021. [PMID: 34731289 DOI: 10.1007/s00281-021-00900-w] [Reference Citation Analysis]
18 Lu X, Chen X, Forney C, Donmez O, Miller D, Parameswaran S, Hong T, Huang Y, Pujato M, Cazares T, Miraldi ER, Ray JP, de Boer CG, Harley JB, Weirauch MT, Kottyan LC. Global discovery of lupus genetic risk variant allelic enhancer activity. Nat Commun 2021;12:1611. [PMID: 33712590 DOI: 10.1038/s41467-021-21854-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
19 He J, Chan T, Hong X, Zheng F, Zhu C, Yin L, Dai W, Tang D, Liu D, Dai Y. Microbiome and Metabolome Analyses Reveal the Disruption of Lipid Metabolism in Systemic Lupus Erythematosus. Front Immunol 2020;11:1703. [PMID: 32849599 DOI: 10.3389/fimmu.2020.01703] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
20 Tang WY, Zhang YH, Zhang YS, Liao Y, Luo JS, Liu JH, Peng CJ, Tang YL, Huang DP, Sun X, Luo XQ. Abnormal thymic B cell activation and impaired T cell differentiation in pristane-induced lupus mice. Immunol Lett 2021;231:49-60. [PMID: 33428991 DOI: 10.1016/j.imlet.2020.12.012] [Reference Citation Analysis]
21 Melki I, Allaeys I, Tessandier N, Lévesque T, Cloutier N, Laroche A, Vernoux N, Becker Y, Benk-Fortin H, Zufferey A, Rollet-Labelle E, Pouliot M, Poirier G, Patey N, Belleannee C, Soulet D, McKenzie SE, Brisson A, Tremblay ME, Lood C, Fortin PR, Boilard E. Platelets release mitochondrial antigens in systemic lupus erythematosus. Sci Transl Med 2021;13:eaav5928. [PMID: 33597264 DOI: 10.1126/scitranslmed.aav5928] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
22 Liao P, He Y, Yang F, Luo G, Zhuang J, Zhai Z, Zhuang L, Lin Z, Zheng J, Sun E. Polydatin effectively attenuates disease activity in lupus-prone mouse models by blocking ROS-mediated NET formation. Arthritis Res Ther 2018;20:254. [PMID: 30419963 DOI: 10.1186/s13075-018-1749-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
23 Tu TY, Yeh CY, Hung YM, Chang R, Chen HH, Wei JC. Association Between a History of Nontyphoidal Salmonella and the Risk of Systemic Lupus Erythematosus: A Population-Based, Case-Control Study. Front Immunol 2021;12:725996. [PMID: 34887848 DOI: 10.3389/fimmu.2021.725996] [Reference Citation Analysis]
24 Tanaka Y, Kubo S, Miyagawa I, Iwata S, Nakayamada S. Lymphocyte phenotype and its application to precision medicine in systemic autoimmune diseases. Semin Arthritis Rheum 2019;48:1146-50. [PMID: 31079846 DOI: 10.1016/j.semarthrit.2019.04.007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
25 Perez RK, Gordon MG, Subramaniam M, Kim MC, Hartoularos GC, Targ S, Sun Y, Ogorodnikov A, Bueno R, Lu A, Thompson M, Rappoport N, Dahl A, Lanata CM, Matloubian M, Maliskova L, Kwek SS, Li T, Slyper M, Waldman J, Dionne D, Rozenblatt-Rosen O, Fong L, Dall'Era M, Balliu B, Regev A, Yazdany J, Criswell LA, Zaitlen N, Ye CJ. Single-cell RNA-seq reveals cell type-specific molecular and genetic associations to lupus. Science 2022;376:eabf1970. [PMID: 35389781 DOI: 10.1126/science.abf1970] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 12.0] [Reference Citation Analysis]
26 Gheita TA, Noor RA, Abualfadl E, Abousehly OS, El-Gazzar II, El Shereef RR, Senara S, Abdalla AM, Khalil NM, ElSaman AM, Tharwat S, Nasef SI, Mohamed EF, Noshy N, El-Essawi DF, Moshrif AH, Fawzy RM, El-Najjar AR, Hammam N, Ismail F, ElKhalifa M, Samy N, Hassan E, Abaza NM, ElShebini E, Fathi HM, Salem MN, Abdel-Fattah YH, Saad E, Abd Elazim MI, Eesa NN, El-Bahnasawy AS, El-Hammady DH, El-Shanawany AT, Ibrahim SE, Said EA, El-Saadany HM, Selim ZI, Fawzy SM, Raafat HA. Adult systemic lupus erythematosus in Egypt: The nation-wide spectrum of 3661 patients and world-wide standpoint. Lupus 2021;30:1526-35. [PMID: 33951965 DOI: 10.1177/09612033211014253] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
27 de Oliveira GLV, Leite AZ, Higuchi BS, Gonzaga MI, Mariano VS. Intestinal dysbiosis and probiotic applications in autoimmune diseases. Immunology. 2017;152:1-12. [PMID: 28556916 DOI: 10.1111/imm.12765] [Cited by in Crossref: 105] [Cited by in F6Publishing: 96] [Article Influence: 21.0] [Reference Citation Analysis]
28 Trujillo-Martín MM, Ramallo-Fariña Y, Del Pino-Sedeño T, Rúa-Figueroa Í, Trujillo-Martín E, Vallejo-Torres L, Imaz-Iglesia I, Sánchez-de-Madariaga R, de Pascual-Medina AM, Serrano-Aguilar P; SLE-CPG-Implementation Group. Effectiveness and cost-effectiveness of a multicomponent intervention to implement a clinical practice guideline for systemic lupus erythematosus: protocol for a cluster-randomized controlled trial. BMC Health Serv Res 2019;19:783. [PMID: 31675957 DOI: 10.1186/s12913-019-4589-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
29 Fatoye F, Gebrye T, Svenson LW. Direct health system costs for systemic lupus erythematosus patients in Alberta, Canada. PLoS One 2021;16:e0251409. [PMID: 33961687 DOI: 10.1371/journal.pone.0251409] [Reference Citation Analysis]
30 Zhang L, Lu GH, Ye S, Wu B, Shen Y, Li T. Treatment adherence and disease burden of individuals with rheumatic diseases admitted as outpatients to a large rheumatology center in Shanghai, China. Patient Prefer Adherence 2017;11:1591-601. [PMID: 29075106 DOI: 10.2147/PPA.S144624] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 2.4] [Reference Citation Analysis]
31 Zhao CN, Mei YJ, Wu GC, Mao YM, Wu Q, Dan YL, Pan HF. Effect of air pollution on hospital admissions for systemic lupus erythematosus in Bengbu, China: a time series study. Lupus 2019;28:1541-8. [PMID: 31615325 DOI: 10.1177/0961203319882503] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
32 Cheng Q, Chen M, Chen X, Chen X, Jiang H, Wu H, Du Y. Novel Long Non-coding RNA Expression Profile of Peripheral Blood Mononuclear Cells Reveals Potential Biomarkers and Regulatory Mechanisms in Systemic Lupus Erythematosus. Front Cell Dev Biol 2021;9:639321. [PMID: 34150746 DOI: 10.3389/fcell.2021.639321] [Reference Citation Analysis]
33 Sanz I. New Perspectives in Rheumatology: May You Live in Interesting Times: Challenges and Opportunities in Lupus Research. Arthritis Rheumatol 2017;69:1552-9. [PMID: 28371318 DOI: 10.1002/art.40109] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
34 Hong S, Healy H, Kassianos AJ. The Emerging Role of Renal Tubular Epithelial Cells in the Immunological Pathophysiology of Lupus Nephritis. Front Immunol 2020;11:578952. [PMID: 33072122 DOI: 10.3389/fimmu.2020.578952] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
35 Abu Bakar F, Shaharir SS, Mohd R, Kamaruzaman L, Mohamed Said MS. Work disability in a multi-ethnic Malaysian systemic lupus erythematosus cohort: A cross-sectional study. Int J Rheum Dis 2019;22:1002-7. [PMID: 30968556 DOI: 10.1111/1756-185X.13572] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
36 Atisha-Fregoso Y, Toz B, Diamond B. Meant to B: B cells as a therapeutic target in systemic lupus erythematosus. J Clin Invest 2021;131:149095. [PMID: 34128474 DOI: 10.1172/JCI149095] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Kaplowitz ET, Ferguson S, Guerra M, Laskin CA, Buyon JP, Petri M, Lockshin MD, Sammaritano LR, Branch DW, Merrill JT, Katz P, Salmon JE. Contribution of Socioeconomic Status to Racial/Ethnic Disparities in Adverse Pregnancy Outcomes Among Women With Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken) 2018;70:230-5. [PMID: 28480528 DOI: 10.1002/acr.23263] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 4.6] [Reference Citation Analysis]
38 Li X, He Z, Ru L, Yuan Y, Yuan Z, Chen P, Xu Z, Wang Q, Song J, Xu Q. Efficacy and Safety of Qinghao Biejia Decoction in the Treatment of Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis. Front Pharmacol 2021;12:669269. [PMID: 34421590 DOI: 10.3389/fphar.2021.669269] [Reference Citation Analysis]
39 Wiles K, Lightstone L. Glomerular Disease in Women. Kidney Int Rep 2018;3:258-70. [PMID: 29725630 DOI: 10.1016/j.ekir.2018.01.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
40 Ramsey-Goldman R, Li J, Dervieux T, Alexander RV. Cell-bound complement activation products in SLE. Lupus Sci Med 2017;4:e000236. [PMID: 29214038 DOI: 10.1136/lupus-2017-000236] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 4.6] [Reference Citation Analysis]
41 Tanaka Y, Mizukami A, Kobayashi A, Ito C, Matsuki T. Disease severity and economic burden in Japanese patients with systemic lupus erythematosus: A retrospective, observational study. Int J Rheum Dis 2018;21:1609-18. [PMID: 30146745 DOI: 10.1111/1756-185X.13363] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
42 Luo G, He Y, Yang F, Zhai Z, Han J, Xu W, Zhang J, Zhuang L, Zhang Y, Li Y, Song R, Luo X, Liang J, Sun E. Blocking GSDME-mediated pyroptosis in renal tubular epithelial cells alleviates disease activity in lupus mice. Cell Death Discov 2022;8. [DOI: 10.1038/s41420-022-00848-2] [Reference Citation Analysis]
43 Cardwell FS, Elliott SJ, Clarke AE. The value of hackathons in integrated knowledge translation (iKT) research: Waterlupus. Health Res Policy Syst 2021;19:138. [PMID: 34819100 DOI: 10.1186/s12961-021-00785-z] [Reference Citation Analysis]
44 Lai R, Zhang X, Qiao K, Gao X, Li S, Zhang R, Qi Y, Peng C. Identification of sequence polymorphisms in the mitochondrial deoxyribonucleic acid displacement-loop region as risk factors for systemic lupus erythematosus. Arch Rheumatol 2021;36:375-80. [PMID: 34870169 DOI: 10.46497/ArchRheumatol.2021.8101] [Reference Citation Analysis]
45 Tummala R, Rouse T, Berglind A, Santiago L. Safety, tolerability and pharmacokinetics of subcutaneous and intravenous anifrolumab in healthy volunteers. Lupus Sci Med 2018;5:e000252. [PMID: 29644080 DOI: 10.1136/lupus-2017-000252] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
46 Jiang M, Near AM, Desta B, Wang X, Hammond ER. Disease and economic burden increase with systemic lupus erythematosus severity 1 year before and after diagnosis: a real-world cohort study, United States, 2004-2015. Lupus Sci Med 2021;8:e000503. [PMID: 34521733 DOI: 10.1136/lupus-2021-000503] [Reference Citation Analysis]
47 Latini A, Ciccacci C, Benedittis G, Novelli L, Ceccarelli F, Conti F, Novelli G, Perricone C, Borgiani P. Altered expression of miR-142, miR-155, miR-499a and of their putative common target MDM2 in systemic lupus erythematosus. Epigenomics 2021;13:5-13. [PMID: 33337917 DOI: 10.2217/epi-2020-0278] [Reference Citation Analysis]
48 Wu J, Ma J, Bao C, Di W, Zhang WH. Pregnancy outcomes among Chinese women with and without systemic lupus erythematosus: a retrospective cohort study. BMJ Open 2018;8:e020909. [PMID: 29654043 DOI: 10.1136/bmjopen-2017-020909] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 5.8] [Reference Citation Analysis]
49 Garrett-Sinha LA, Kearly A, Satterthwaite AB. The Role of the Transcription Factor Ets1 in Lupus and Other Autoimmune Diseases. Crit Rev Immunol 2016;36:485-510. [PMID: 28845756 DOI: 10.1615/CritRevImmunol.2017020284] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
50 Connelly K, Morand EF. Systemic lupus erythematosus: a clinical update. Intern Med J 2021;51:1219-28. [PMID: 34423550 DOI: 10.1111/imj.15448] [Reference Citation Analysis]
51 Koh JH, Park EK, Lee HN, Kim Y, Kim GT, Suh YS, Kim HO, Lee SG. Clinical characteristics and survival of 413 patients with systemic lupus erythematosus in southeastern areas of South Korea: A multicenter retrospective cohort study. Int J Rheum Dis 2020;23:92-100. [PMID: 31802639 DOI: 10.1111/1756-185X.13761] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
52 Pradhan V, Pandit P, Surve P, Lecerf M, Rajadhyaksha A, Nadkar M, Khadilkar PV, Chougule DA, Naigaonkar AA, Lacroix-Desmazes S, Bayry J, Ghosh K, Kaveri SV. Catalytic antibodies in patients with systemic lupus erythematosus. Eur J Rheumatol 2018;5:173-8. [PMID: 30185370 DOI: 10.5152/eurjrheum.2018.17194] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
53 Selvaraja M, Chin VK, Abdullah M, Arip M, Amin-Nordin S. HLA-DRB1*04 as a Risk Allele to Systemic Lupus Erythematosus and Lupus Nephritis in the Malay Population of Malaysia. Front Med (Lausanne) 2020;7:598665. [PMID: 33644084 DOI: 10.3389/fmed.2020.598665] [Reference Citation Analysis]
54 Choi MY, Fritzler MJ. Autoantibodies in SLE: prediction and the p value matrix. Lupus 2019;28:1285-93. [PMID: 31399014 DOI: 10.1177/0961203319868531] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
55 Wincup C, Radziszewska A. Abnormal Mitochondrial Physiology in the Pathogenesis of Systemic Lupus Erythematosus. Rheum Dis Clin North Am 2021;47:427-39. [PMID: 34215372 DOI: 10.1016/j.rdc.2021.05.001] [Reference Citation Analysis]
56 Barber MRW, Hanly JG, Su L, Urowitz MB, St Pierre Y, Romero-Diaz J, Gordon C, Bae SC, Bernatsky S, Wallace DJ, Isenberg DA, Rahman A, Ginzler EM, Petri M, Bruce IN, Fortin PR, Gladman DD, Sanchez-Guerrero J, Ramsey-Goldman R, Khamashta MA, Aranow C, Mackay M, Alarcón GS, Manzi S, Nived O, Jönsen A, Zoma AA, van Vollenhoven RF, Ramos-Casals M, Ruiz-Irastorza G, Lim SS, Kalunian KC, Inanc M, Kamen DL, Peschken CA, Jacobsen S, Askanase A, Theriault C, Farewell V, Clarke AE. Economic Evaluation of Lupus Nephritis in the Systemic Lupus International Collaborating Clinics Inception Cohort Using a Multistate Model Approach. Arthritis Care Res (Hoboken) 2018;70:1294-302. [PMID: 29193883 DOI: 10.1002/acr.23480] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
57 Han J, Ren G, Xu Z, Qi W, Shang Y, Wen S, Luo Y. Exploring the relationship between systemic lupus erythematosus and osteoporosis based on bioinformatics. Lupus 2022;:9612033211073909. [PMID: 35067074 DOI: 10.1177/09612033211073909] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
58 Mao YM, He YS, Wu GC, Hu YQ, Xiang K, Liao T, Yan YL, Yang XK, Shuai ZW, Wang GH, Pan HF, Ye DQ. Association of MALAT-1 gene single nucleotide polymorphisms with genetic susceptibility to systemic lupus erythematosus. Lupus 2021;30:1923-30. [PMID: 34482739 DOI: 10.1177/09612033211040366] [Reference Citation Analysis]
59 Peschken CA. Health Disparities in Systemic Lupus Erythematosus. Rheum Dis Clin North Am 2020;46:673-83. [PMID: 32981644 DOI: 10.1016/j.rdc.2020.07.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
60 Li Z, Wang Y, Ding Y, Repp L, Kwon GS, Hu Q. Cell‐Based Delivery Systems: Emerging Carriers for Immunotherapy. Adv Funct Mater 2021;31:2100088. [DOI: 10.1002/adfm.202100088] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 18.0] [Reference Citation Analysis]
61 Hammond ER, Tummala R, Berglind A, Syed F, Wang X, Desta B, Nab H. Study protocol for the international Systemic Lupus Erythematosus Prospective Observational Cohort Study (SPOCS): understanding lupus and the role of type I interferon gene signature. BMJ Open 2020;10:e036563. [PMID: 32873668 DOI: 10.1136/bmjopen-2019-036563] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
62 DeQuattro K, Yelin E. Socioeconomic Status, Health Care, and Outcomes in Systemic Lupus Erythematosus. Rheum Dis Clin North Am 2020;46:639-49. [PMID: 32981641 DOI: 10.1016/j.rdc.2020.07.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
63 Zhao N, Smargiassi A, Hudson M, Fritzler MJ, Bernatsky S. Investigating associations between anti-nuclear antibody positivity and combined long-term exposures to NO2, O3, and PM2.5 using a Bayesian kernel machine regression approach. Environment International 2020;136:105472. [DOI: 10.1016/j.envint.2020.105472] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
64 Essouma M, Nkeck JR, Endomba FT, Bigna JJ, Singwe-Ngandeu M, Hachulla E. Systemic lupus erythematosus in Native sub-Saharan Africans: A systematic review and meta-analysis. J Autoimmun 2020;106:102348. [PMID: 31668352 DOI: 10.1016/j.jaut.2019.102348] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
65 Wolf VL, Ryan MJ. Autoimmune Disease-Associated Hypertension. Curr Hypertens Rep 2019;21:10. [PMID: 30712132 DOI: 10.1007/s11906-019-0914-2] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 6.3] [Reference Citation Analysis]
66 Gao R, Wu L, Shi P, Sang N, Hao M, Wu G. The impact of distress disclosure and anxiety on the association between social support and quality of life among Chinese women with systemic lupus erythematosus. Front Psychiatry 2022;13:893235. [DOI: 10.3389/fpsyt.2022.893235] [Reference Citation Analysis]
67 Lindblom J, Gomez A, Borg A, Emamikia S, Ladakis D, Matilla J, Pehr M, Cobar F, Enman Y, Heintz E, Regardt M, Parodis I. EQ-5D-3L full health state discriminates between drug and placebo in clinical trials of systemic lupus erythematosus. Rheumatology (Oxford) 2021;60:4703-16. [PMID: 33502473 DOI: 10.1093/rheumatology/keab080] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
68 Matsuda S, Ohtomo T, Tomizawa S, Miyano Y, Mogi M, Kuriki H, Nakayama T, Watanabe S. Incorporating Unstructured Patient Narratives and Health Insurance Claims Data in Pharmacovigilance: Natural Language Processing Analysis of Patient-Generated Texts About Systemic Lupus Erythematosus. JMIR Public Health Surveill 2021;7:e29238. [PMID: 34255719 DOI: 10.2196/29238] [Reference Citation Analysis]
69 Kailashiya V, Sharma HB, Kailashiya J. Role of CTLA4 A49G polymorphism in systemic lupus erythematosus and its geographical distribution. J Clin Pathol 2019;72:659-62. [DOI: 10.1136/jclinpath-2019-206013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
70 Tse K, Sangodkar S, Bloch L, Arntsen K, Bae SC, Bruce IN, Connolly-Strong E, Costenbader KH, Dickerson B, Dörner T, Evans S, Kalunian K, Kao AH, Manzi S, Morand EF, Raymond SC, Rovin BH, Schanberg LE, Von Feldt JM, Werth VP, Williams Derricott A, Zook D, Franson T, Getz K, Peña Y, Hanrahan LM; ALPHA Project Global Advisory Committee. The ALPHA Project: Establishing consensus and prioritisation of global community recommendations to address major challenges in lupus diagnosis, care, treatment and research. Lupus Sci Med 2021;8:e000433. [PMID: 33563729 DOI: 10.1136/lupus-2020-000433] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
71 Gilcrease GW, Padovan D, Heffler E, Peano C, Massaglia S, Roccatello D, Radin M, Cuadrado MJ, Sciascia S. Is air pollution affecting the disease activity in patients with systemic lupus erythematosus? State of the art and a systematic literature review. Eur J Rheumatol 2020;7:31-4. [PMID: 32023206 DOI: 10.5152/eurjrheum.2019.19141] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
72 Elera-fitzcarrald C, Alva M, Gamboa-cardenas R, Mora-trujillo CS, Zevallos F, García-poma A, Medina M, Rodriguez-bellido Z, Perich-campos RA, Pastor-asurza CA, Segami MI, Ugarte-gil MF. Factors associated with health-related quality of life in Peruvian patients with systemic lupus erythematosus. Lupus 2018;27:913-9. [DOI: 10.1177/0961203317751062] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
73 Sun YH, Leong PY, Huang JY, Wei JC. Increased risk of being diagnosed with endometriosis in patients with Systemic lupus erythematosus: a population-based cohort study in Taiwan. Sci Rep 2022;12:13336. [PMID: 35922461 DOI: 10.1038/s41598-022-17343-4] [Reference Citation Analysis]
74 Wang T, Wang H, Qiu L, Wu L, Ling H, Xue Y, Zhou Y, Chen H, Ye D, Wang B, Ciccacci C. Association of HLA-DR1, HLA-DR13, and HLA-DR16 Polymorphisms with Systemic Lupus Erythematosus: A Meta-Analysis. Journal of Immunology Research 2022;2022:1-17. [DOI: 10.1155/2022/8140982] [Reference Citation Analysis]
75 Fatoye F, Gebrye T, Svenson LW. Real-world incidence and prevalence of systemic lupus erythematosus in Alberta, Canada. Rheumatol Int 2018;38:1721-6. [PMID: 29987494 DOI: 10.1007/s00296-018-4091-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 4.5] [Reference Citation Analysis]
76 Beswick DM, Mace JC, Soler ZM, Rudmik L, Alt JA, Smith KA, Detwiller KY, Ramakrishnan VR, Smith TL. Socioeconomic status impacts postoperative productivity loss and health utility changes in refractory chronic rhinosinusitis. Int Forum Allergy Rhinol 2019;9:1000-9. [PMID: 31246360 DOI: 10.1002/alr.22374] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
77 Ciccia F, Ferrante A, Guggino G, Triolo G. The role of the gastrointestinal tract in the pathogenesis of rheumatic diseases. Best Pract Res Clin Rheumatol 2016;30:889-900. [PMID: 27964794 DOI: 10.1016/j.berh.2016.10.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
78 Konishi K, Nakamura K, Hanada Y, Kitanaga Y, Kubo S, Kinugasa F, Yamajuku D, Maeda M, Yamamoto N, Minematsu T, Ohbuchi M, Kondo Y, Sumida T. Preclinical Characterization of ASP2713, a Novel Igβ and FcγRIIB Cross-Linking Antibody, for Prediction of Human Pharmacokinetics and Clinically Effective Dose. J Pharm Sci 2022:S0022-3549(22)00250-7. [PMID: 35700799 DOI: 10.1016/j.xphs.2022.06.006] [Reference Citation Analysis]
79 Ajeganova S, Gustafsson T, Lindberg L, Hafström I, Frostegård J. Similar progression of carotid intima-media thickness in 7-year surveillance of patients with mild SLE and controls, but this progression is still promoted by dyslipidaemia, lower HDL levels, hypertension, history of lupus nephritis and a higher prednisolone usage in patients. Lupus Sci Med 2020;7:e000362. [PMID: 32095248 DOI: 10.1136/lupus-2019-000362] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
80 Fanouriakis A, Tziolos N, Bertsias G, Boumpas DT. Update οn the diagnosis and management of systemic lupus erythematosus. Ann Rheum Dis 2021;80:14-25. [PMID: 33051219 DOI: 10.1136/annrheumdis-2020-218272] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 10.5] [Reference Citation Analysis]
81 Hernández-Doño S, Jakez-Ocampo J, Márquez-García JE, Ruiz D, Acuña-Alonzo V, Lima G, Llorente L, Tovar-Méndez VH, García-Silva R, Granados J, Zúñiga J, Vargas-Alarcón G. Heterogeneity of Genetic Admixture Determines SLE Susceptibility in Mexican. Front Genet 2021;12:701373. [PMID: 34413879 DOI: 10.3389/fgene.2021.701373] [Reference Citation Analysis]
82 Hasan B, Fike A, Hasni S. Health disparities in systemic lupus erythematosus-a narrative review. Clin Rheumatol 2022. [PMID: 35907971 DOI: 10.1007/s10067-022-06268-y] [Reference Citation Analysis]
83 Zhang M, Li SS, Xie QM, Xu JH, Sun XX, Pan FM, Xu SQ, Liu SX, Tao JH, Liu S, Cai J, Chen PL, Qian L, Wang CH, Liang CM, Huang HL, Pan HF, Su H, Zou YF. Associations of HSP90AA2 gene polymorphisms with disease susceptibility, glucocorticoids efficacy and health-related quality of life in Chinese systemic lupus erythematosus patients. Genes Genomics 2018;40:1069-79. [PMID: 29907909 DOI: 10.1007/s13258-018-0714-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
84 Salgado-galicia NA, Hernández-doño S, Ruiz-gómez D, Jakez-ocampo J, Zúñiga J, Vargas-alarcón G, Acuña V, Hernández MT, Márquez-garcía JE, García-lechuga M, Llorente L, Lima G, Pineda C, Yu N, Yunis E, Granados J. The role of socioeconomic status in the susceptibility to develop systemic lupus erythematosus in Mexican patients. Clin Rheumatol 2020;39:2151-61. [DOI: 10.1007/s10067-020-04928-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
85 Lu L, Wang H, Liu X, Tan L, Qiao X, Ni J, Sun Y, Liang J, Hou Y, Dou H. Pyruvate kinase isoform M2 impairs cognition in systemic lupus erythematosus by promoting microglial synaptic pruning via the β-catenin signaling pathway. J Neuroinflammation 2021;18:229. [PMID: 34645459 DOI: 10.1186/s12974-021-02279-9] [Reference Citation Analysis]
86 Owen KA, Grammer AC, Lipsky PE. Deconvoluting the heterogeneity of SLE: The contribution of ancestry. J Allergy Clin Immunol 2021:S0091-6749(21)01762-0. [PMID: 34857396 DOI: 10.1016/j.jaci.2021.11.005] [Reference Citation Analysis]
87 Sagy I, Cohen Y, Nahum Y, Pokroy-Shapira E, Abu-Shakra M, Molad Y. Lower socioeconomic status worsens outcome of patients with systemic lupus erythematosus independently of access to healthcare. Lupus 2022;:9612033221084518. [PMID: 35341361 DOI: 10.1177/09612033221084518] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
88 Jin Z, Yang C, Xiao C, Wang Z, Zhang S, Ren J. Systemic lupus erythematosus and risk of sexual dysfunction: A systematic review and Meta-Analysis. Lupus 2021;30:238-47. [PMID: 33210559 DOI: 10.1177/0961203320974081] [Reference Citation Analysis]
89 Bifani BE, Sato TO, Dos Santos GB, Serrão PRMDS, Rocha APR, Carvalho C. Pelvic floor dysfunctions in women with systemic lupus erythematosus: A cross-sectional study. Int Urogynecol J 2022. [PMID: 35913612 DOI: 10.1007/s00192-022-05310-6] [Reference Citation Analysis]
90 Wang Y, Shu W, Lin S, Wu J, Jiang M, Li S, Liu C, Li R, Pei C, Ding Y, Wan J, Di W. Hollow Cobalt Oxide/Carbon Hybrids Aid Metabolic Encoding for Active Systemic Lupus Erythematosus during Pregnancy. Small 2022;:e2106412. [PMID: 35064740 DOI: 10.1002/smll.202106412] [Reference Citation Analysis]
91 Graef ER, Liew JW, Putman MS, Simard JF, Sirotich E, Berenbaum F, Duarte-García A, Grainger R, Harrison C, Konig MF, Korsten P, Proulx L, Richards DP, Robinson PC, Sattui SE, Ugarte-Gil MF, Young KJ, Kim AH, Sparks JA; COVID-19 Global Rheumatology Alliance. Festina lente: hydroxychloroquine, COVID-19 and the role of the rheumatologist. Ann Rheum Dis 2020;79:734-6. [PMID: 32295786 DOI: 10.1136/annrheumdis-2020-217480] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 11.5] [Reference Citation Analysis]
92 Namas R, Salih B. Maternal and fetal outcomes in systemic lupus erythematosus. Ibnosina J Med Biomed Sci 2020;12:6. [DOI: 10.4103/ijmbs.ijmbs_26_20] [Reference Citation Analysis]
93 Rodriguez-Hernandez A, Ortiz-Orendain J, Alvarez-Palazuelos LE, Gonzalez-Lopez L, Gamez-Nava JI, Zavala-Cerna MG. Seizures in systemic lupus erythematosus: A scoping review. Seizure 2021;86:161-7. [PMID: 33626435 DOI: 10.1016/j.seizure.2021.02.021] [Reference Citation Analysis]
94 Barros LCM, Lima MES, Pereira RMM, Vasconcelos LAA, Rabelo WC. Juvenile lupus, cytomegalovirus infection and cardiac tamponade: case report. Rev Paul Pediatr 2021;40:e2020291. [PMID: 34495276 DOI: 10.1590/1984-0462/2022/40/2020291] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
95 Kiadaliri AA, Mohammad AJ, Englund M. Hospitalizations due to systemic connective tissue diseases: Secular trends and regional disparities in Sweden, 1998-2016. Int J Rheum Dis 2018;21:1900-6. [PMID: 30168267 DOI: 10.1111/1756-185X.13341] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
96 Poh YJ, Baptista B, D'Cruz DP. Subcutaneous and intravenous belimumab in the treatment of systemic lupus erythematosus: a review of data on subcutaneous and intravenous administration. Expert Rev Clin Immunol 2017;13:925-38. [PMID: 28847197 DOI: 10.1080/1744666X.2017.1371592] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
97 van der Heijde D, Daikh DI, Betteridge N, Burmester GR, Hassett AL, Matteson EL, van Vollenhoven R, Lakhanpal S. Common Language Description of the Term Rheumatic and Musculoskeletal Diseases (RMDs) for Use in Communication With the Lay Public, Healthcare Providers, and Other Stakeholders Endorsed by the European League Against Rheumatism (EULAR) and the American Co. Arthritis Rheumatol 2018;70:826-31. [DOI: 10.1002/art.40448] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
98 Kenny EF, Raupach B, Abu Abed U, Brinkmann V, Zychlinsky A. Dnase1-deficient mice spontaneously develop a systemic lupus erythematosus-like disease. Eur J Immunol 2019;49:590-9. [PMID: 30758851 DOI: 10.1002/eji.201847875] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
99 Prada S, Perez A, Nieto-aristizábal I, Tobón G. Direct cost of lupus care in the developing world: the case of Colombia. Lupus 2019;28:970-6. [DOI: 10.1177/0961203319856093] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
100 Yu KG, Shen JJ, Kim PC, Kim SJ, Lee SW, Byun D, Yoo JW, Hwang J. Trends of Hospital Palliative Care Utilization and Its Associated Factors Among Patients With Systemic Lupus Erythematosus in the United States From 2005 to 2014. Am J Hosp Palliat Care 2020;37:164-71. [PMID: 31793335 DOI: 10.1177/1049909119891999] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
101 Matsuo Y, Shimizu T, Gon Y, Sato M, Matsushita S, Yoshioka T. Comment on: Beneficial effect of Mediterranean diet on disease activity and cardiovascular risk in systemic lupus erythematosus patients: a cross-sectional study. Rheumatology (Oxford) 2021;60:e339-40. [PMID: 33764391 DOI: 10.1093/rheumatology/keab281] [Reference Citation Analysis]
102 Wang Q, Xie L, Wang L, Li X, Xu L, Chen P. Readability in printed education materials for Chinese patients with systemic lupus erythematosus: a mixed-method design. BMJ Open 2020;10:e038091. [PMID: 33055117 DOI: 10.1136/bmjopen-2020-038091] [Reference Citation Analysis]
103 Cao L, Zhang R, Wang Y, Hu X, Yong L, Li B, Ge H, Chen W, Zhen Q, Yu Y, Mao Y, Li Z, Fan W, Sun L. Fine Mapping Analysis of the MHC Region to Identify Variants Associated With Chinese Vitiligo and SLE and Association Across These Diseases. Front Immunol 2021;12:758652. [PMID: 35082778 DOI: 10.3389/fimmu.2021.758652] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
104 Tumurkhuu G, Montano E, Jefferies C. Innate Immune Dysregulation in the Development of Cardiovascular Disease in Lupus. Curr Rheumatol Rep 2019;21. [DOI: 10.1007/s11926-019-0842-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
105 Melki I, Allaeys I, Tessandier N, Mailhot B, Cloutier N, Campbell RA, Rowley JW, Salem D, Zufferey A, Laroche A, Lévesque T, Patey N, Rauch J, Lood C, Droit A, McKenzie SE, Machlus KR, Rondina MT, Lacroix S, Fortin PR, Boilard E. FcγRIIA expression accelerates nephritis and increases platelet activation in systemic lupus erythematosus. Blood 2020;136:2933-45. [PMID: 33331924 DOI: 10.1182/blood.2020004974] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
106 Do SC, Druzin ML. Systemic lupus erythematosus in pregnancy: high risk, high reward. Curr Opin Obstet Gynecol 2019;31:120-6. [PMID: 30676534 DOI: 10.1097/GCO.0000000000000528] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
107 Xie X, Yang H, Nie A, Chen H, Li J. Predictors of medication nonadherence in patients with systemic lupus erythematosus in Sichuan: a cross-sectional study. Patient Prefer Adherence 2018;12:1505-11. [PMID: 30197502 DOI: 10.2147/PPA.S169776] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
108 Du X, Chen H, Zhuang Y, Zhao Q, Shen B. Medication Adherence in Chinese Patients With Systemic Lupus Erythematosus. J Clin Rheumatol 2020;26:94-8. [DOI: 10.1097/rhu.0000000000000952] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
109 Xu WD, Liu XY, Su LC, Huang AF. Association of MASP2 levels and MASP2 gene polymorphisms with systemic lupus erythematosus. J Cell Mol Med 2020;24:10432-43. [PMID: 32677764 DOI: 10.1111/jcmm.15656] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
110 Hamijoyo L, Putri M, Alita VR, Atik N, Syamsunarno MRA. Fatty acid binding protein 4 (FABP4) and metabolic-related parameters in systemic lupus erythematosus active and non-active episode. Lupus 2021;30:1133-9. [PMID: 33840283 DOI: 10.1177/09612033211006908] [Reference Citation Analysis]
111 Tian J, Zhou H, Fang D, Yi P, Cao P, Liu J, Xiong F, Zhang B, Liu Y, Tsokos GC, Lu Q. The global burden of heterogeneity of lupus erythematosus interventional trials. J Autoimmun 2022;128:102798. [PMID: 35182896 DOI: 10.1016/j.jaut.2022.102798] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
112 Dantas LO, Weber S, Osani MC, Bannuru RR, McAlindon TE, Kasturi S. Mobile health technologies for the management of systemic lupus erythematosus: a systematic review. Lupus 2020;29:144-56. [PMID: 31924145 DOI: 10.1177/0961203319897139] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
113 Lu MC, Koo M. Effects of Exercise Intervention on Health-Related Quality of Life in Patients with Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis of Controlled Trials. Healthcare (Basel) 2021;9:1215. [PMID: 34574989 DOI: 10.3390/healthcare9091215] [Reference Citation Analysis]
114 Yariwake VY, Torres JI, Dos Santos ARP, Freitas SCF, De Angelis K, Farhat SCL, Câmara NOS, Veras MM. Chronic exposure to PM2.5 aggravates SLE manifestations in lupus-prone mice. Part Fibre Toxicol 2021;18:15. [PMID: 33766080 DOI: 10.1186/s12989-021-00407-0] [Reference Citation Analysis]
115 Panwar B, Schmiedel BJ, Liang S, White B, Rodriguez E, Kalunian K, McKnight AJ, Soloff R, Seumois G, Vijayanand P, Ay F. Multi-cell type gene coexpression network analysis reveals coordinated interferon response and cross-cell type correlations in systemic lupus erythematosus. Genome Res 2021;31:659-76. [PMID: 33674349 DOI: 10.1101/gr.265249.120] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
116 Goh H, Kwan YH, Seah Y, Low LL, Fong W, Thumboo J. A systematic review of the barriers affecting medication adherence in patients with rheumatic diseases. Rheumatol Int 2017;37:1619-28. [PMID: 28681249 DOI: 10.1007/s00296-017-3763-9] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
117 Suárez-Avellaneda A, Quintana JH, Aragón CC, Gallego LM, Gallego CN, Bolaños JD, A Guerra M, Ochoa ME, Granados M, Ruiz-Ordoñez I, Tobón GJ. Systemic lupus erythematosus in the intensive care unit: a systematic review. Lupus 2020;29:1364-76. [PMID: 32723062 DOI: 10.1177/0961203320941941] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
118 Harley ITW, Sawalha AH. Systemic lupus erythematosus as a genetic disease. Clin Immunol 2022;:108953. [PMID: 35149194 DOI: 10.1016/j.clim.2022.108953] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
119 Jorge AM, Smith D, Wu Z, Chowdhury T, Costenbader K, Zhang Y, Choi HK, Feldman CH, Zhao Y. Exploration of machine learning methods to predict systemic lupus erythematosus hospitalizations. Lupus 2022;:9612033221114805. [PMID: 35835534 DOI: 10.1177/09612033221114805] [Reference Citation Analysis]
120 Gergianaki I, Fanouriakis A, Repa A, Tzanakakis M, Adamichou C, Pompieri A, Spirou G, Bertsias A, Kabouraki E, Tzanakis I, Chatzi L, Sidiropoulos P, Boumpas DT, Bertsias GK. Epidemiology and burden of systemic lupus erythematosus in a Southern European population: data from the community-based lupus registry of Crete, Greece. Ann Rheum Dis 2017;76:1992-2000. [DOI: 10.1136/annrheumdis-2017-211206] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 6.4] [Reference Citation Analysis]
121 Gergianaki I, Bortoluzzi A, Bertsias G. Update on the epidemiology, risk factors, and disease outcomes of systemic lupus erythematosus. Best Pract Res Clin Rheumatol 2018;32:188-205. [PMID: 30527426 DOI: 10.1016/j.berh.2018.09.004] [Cited by in Crossref: 34] [Cited by in F6Publishing: 25] [Article Influence: 8.5] [Reference Citation Analysis]
122 Li D, Qi J, Wang J, Pan Y, Li J, Xia X, Dou H, Hou Y. Protective effect of dihydroartemisinin in inhibiting senescence of myeloid-derived suppressor cells from lupus mice via Nrf2/HO-1 pathway. Free Radical Biology and Medicine 2019;143:260-74. [DOI: 10.1016/j.freeradbiomed.2019.08.013] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
123 Yeo AL, Koelmeyer R, Kandane‐rathnayake R, Golder V, Hoi A, Huq M, Hammond E, Nab H, Nikpour M, Morand EF. Lupus Low Disease Activity State and Reduced Direct Health Care Costs in Patients With Systemic Lupus Erythematosus. Arthritis Care Res 2020;72:1289-95. [DOI: 10.1002/acr.24023] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
124 Mendoza-pinto C, Etchegaray-morales I, Garcia-carrasco M, Munguía-realpozo P, Méndez-martínez S, Osorio-peña AD, Montiel-jarquín ÁJ. Twenty-year trends in all-cause mortality of patients with systemic lupus erythematosus in Mexico: Results from a nationwide health registry. Lupus. [DOI: 10.1177/09612033221078228] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
125 Luo Y, Fan X, Jiang C, Ramos-Rodriguez A, Wen Y, Zhang J, Huang F, Guan X, Xu J. Systemic Lupus Erythematosus and Angioedema: A Cross-Sectional Study From the National Inpatient Sample. Arch Rheumatol 2019;34:301-7. [PMID: 31598596 DOI: 10.5606/ArchRheumatol.2019.7149] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
126 Hawker K, Barnabe C, Barber CEH. A scoping Review of tools used to assess patient Complexity in rheumatic disease. Health Expect 2021;24:556-65. [PMID: 33595914 DOI: 10.1111/hex.13200] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
127 Yin X, Kim K, Suetsugu H, Bang SY, Wen L, Koido M, Ha E, Liu L, Sakamoto Y, Jo S, Leng RX, Otomo N, Laurynenka V, Kwon YC, Sheng Y, Sugano N, Hwang MY, Li W, Mukai M, Yoon K, Cai M, Ishigaki K, Chung WT, Huang H, Takahashi D, Lee SS, Wang M, Karino K, Shim SC, Zheng X, Miyamura T, Kang YM, Ye D, Nakamura J, Suh CH, Tang Y, Motomura G, Park YB, Ding H, Kuroda T, Choe JY, Li C, Niiro H, Park Y, Shen C, Miyamoto T, Ahn GY, Fei W, Takeuchi T, Shin JM, Li K, Kawaguchi Y, Lee YK, Wang Y, Amano K, Park DJ, Yang W, Tada Y, Yamaji K, Shimizu M, Atsumi T, Suzuki A, Sumida T, Okada Y, Matsuda K, Matsuo K, Kochi Y, Kottyan LC, Weirauch MT, Parameswaran S, Eswar S, Salim H, Chen X, Yamamoto K, Harley JB, Ohmura K, Kim TH, Yang S, Yamamoto T, Kim BJ, Shen N, Ikegawa S, Lee HS, Zhang X, Terao C, Cui Y, Bae SC; Japanese Research Committee on Idiopathic Osteonecrosis of the Femoral Head. Meta-analysis of 208370 East Asians identifies 113 susceptibility loci for systemic lupus erythematosus. Ann Rheum Dis 2021;80:632-40. [PMID: 33272962 DOI: 10.1136/annrheumdis-2020-219209] [Cited by in Crossref: 5] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
128 Lima SC, Gomes da Silva IIF, Nascimento DQ, de Moura RR, Mesquita MDS, Asano NMJ, Fernandes GV, Valente LM, Rushansky E, Mariano MHQA, Xavier RM, Chies JAB, Crovella S, Sandrin-Garcia P. CIITA gene polymorphism (rs3087456) in systemic lupus erythematosus and rheumatoid arthritis: A population-based cohort study. Int J Immunogenet 2021. [PMID: 34180145 DOI: 10.1111/iji.12548] [Reference Citation Analysis]
129 Manzi S, Raymond S, Tse K, Peña Y, Anderson A, Arntsen K, Bae SC, Bruce I, Dörner T, Getz K, Hanrahan L, Kao A, Morand E, Rovin B, Schanberg LE, Von Feldt JM, Werth VP, Costenbader K. Global consensus building and prioritisation of fundamental lupus challenges: the ALPHA project. Lupus Sci Med 2019;6:e000342. [PMID: 31413854 DOI: 10.1136/lupus-2019-000342] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
130 Zhao Y, Qi Y, Liu X, Cui Y, Zhao Z, Ciccacci C. Efficiency of Disease and Disease Activity Diagnosis Models of Systemic Lupus Erythematosus Based on Protein Array Analysis. Journal of Immunology Research 2022;2022:1-14. [DOI: 10.1155/2022/1830431] [Reference Citation Analysis]
131 Dos Santos M, Veronese FV, Moresco RN. Uric acid and kidney damage in systemic lupus erythematosus. Clin Chim Acta 2020;508:197-205. [PMID: 32428504 DOI: 10.1016/j.cca.2020.05.034] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
132 Keeling SO, Bissonauth A, Bernatsky S, Vandermeer B, Fortin PR, Gladman DD, Peschken C, Urowitz MB. Practice Variations in the Diagnosis, Monitoring, and Treatment of Systemic Lupus Erythematosus in Canada. J Rheumatol 2018;45:1440-7. [PMID: 30068762 DOI: 10.3899/jrheum.171307] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
133 Borgia RE, Alarcón GS. Community-Engaged Research to Address Health Disparities in Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken) 2021;73:305-7. [PMID: 32841549 DOI: 10.1002/acr.24432] [Reference Citation Analysis]
134 Poh YJ, Yii IYL, Goh LH, Li HH, Yang L, Tan HK, Thumboo J, Tan LK. Maternal and Fetal Outcomes in Systemic Lupus Erythematosus Pregnancies. Ann Acad Med Singap 2021;49:963-70. [DOI: 10.47102/annals-acadmedsg.2020373] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
135 Zhang L, Geng S, Qian L, Ye S, Wang X, Lu G, Ding Y, Li T. Multidisciplinary care in patients with systemic lupus erythematosus: a randomized controlled trial in China. Int J Clin Pharm 2019;41:1247-55. [PMID: 31240553 DOI: 10.1007/s11096-019-00870-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
136 Aarntzen EHJG, Noriega-Álvarez E, Artiko V, Dias AH, Gheysens O, Glaudemans AWJM, Lauri C, Treglia G, van den Wyngaert T, van Leeuwen FWB, Terry SYA. EANM recommendations based on systematic analysis of small animal radionuclide imaging in inflammatory musculoskeletal diseases. EJNMMI Res 2021;11:85. [PMID: 34487263 DOI: 10.1186/s13550-021-00820-8] [Reference Citation Analysis]
137 Dixon J, Cardwell FS, Clarke AE, Elliott SJ. Choices are inevitable: A qualitative exploration of the lifecosts of systemic lupus erythematosus. Chronic Illn 2020;:1742395320910490. [PMID: 32183564 DOI: 10.1177/1742395320910490] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
138 Mitchell AM, Michels AW. T cell receptor sequencing in autoimmunity. J Life Sci (Westlake Village) 2020;2:38-58. [PMID: 33364626 DOI: 10.36069/jols/20201203] [Reference Citation Analysis]
139 Barber MRW, Drenkard C, Falasinnu T, Hoi A, Mak A, Kow NY, Svenungsson E, Peterson J, Clarke AE, Ramsey-Goldman R. Global epidemiology of systemic lupus erythematosus. Nat Rev Rheumatol 2021. [PMID: 34345022 DOI: 10.1038/s41584-021-00668-1] [Reference Citation Analysis]
140 Thanou A, Merrill JT. New Trials in Lupus and where Are we Going. Curr Rheumatol Rep 2018;20. [DOI: 10.1007/s11926-018-0745-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
141 Rezaieyazdi Z, Tabaei S, Ravanshad Y, Akhtari J, Mehrad-Majd H. No association between the risk of breast cancer and systemic lupus erythematosus: evidence from a meta-analysis. Clin Rheumatol 2018;37:1511-9. [PMID: 29294194 DOI: 10.1007/s10067-017-3950-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
142 Lim LSH, Pullenayegum E, Lim L, Gladman D, Feldman B, Silverman E. From Childhood to Adulthood: The Trajectory of Damage in Patients With Juvenile-Onset Systemic Lupus Erythematosus. Arthritis Care Res 2017;69:1627-35. [DOI: 10.1002/acr.23199] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 4.6] [Reference Citation Analysis]
143 Shandil RK, Dhup S, Narayanan S, Mishra R. Evaluation of the Therapeutic Potential of Mesenchymal Stem Cells (MSCs) in Preclinical Models of Autoimmune Diseases. Stem Cells International 2022;2022:1-8. [DOI: 10.1155/2022/6379161] [Reference Citation Analysis]
144 Xiao L, Zhan F, Lin S. Clinical Values of the Identified Hub Genes in Systemic Lupus Erythematosus. Front Immunol 2022;13:844025. [PMID: 35757684 DOI: 10.3389/fimmu.2022.844025] [Reference Citation Analysis]
145 Holcar M, Goropevšek A, Avčin T. Altered Homeostasis of Regulatory T Lymphocytes and Differential Regulation of STAT1/STAT5 in CD4+ T Lymphocytes in Childhood-onset Systemic Lupus Erythematosus. J Rheumatol 2020;47:557-66. [PMID: 31263070 DOI: 10.3899/jrheum.181418] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
146 Nie M, Chen G, Zhao C, Gan J, Alip M, Zhao Y, Sun L. Bio-inspired adhesive porous particles with human MSCs encapsulation for systemic lupus erythematosus treatment. Bioact Mater 2021;6:84-90. [PMID: 32817916 DOI: 10.1016/j.bioactmat.2020.07.018] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
147 Larsen JL, Hall EOC, Jacobsen S, Birkelund R. The existential experience of everyday life with systemic lupus erythematosus. J Adv Nurs 2018;74:1170-9. [PMID: 29350776 DOI: 10.1111/jan.13525] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
148 Garton J, Barron MD, Ratliff ML, Webb CF. New Frontiers: ARID3a in SLE. Cells 2019;8:E1136. [PMID: 31554207 DOI: 10.3390/cells8101136] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
149 Etchegaray-Morales I, Méndez-Martínez S, Jiménez-Hernández C, Mendoza-Pinto C, Alonso-García NE, Montiel-Jarquín A, López-Colombo A, García-Villaseñor A, Cardiel MH, García-Carrasco M. Factors Associated with Health-Related Quality of Life in Mexican Lupus Patients Using the LupusQol. PLoS One 2017;12:e0170209. [PMID: 28114336 DOI: 10.1371/journal.pone.0170209] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
150 Miguel TS, Souto ALM, Rocha FBDM, Rossett T, Rocha FBDM, Damasceno EDF. Retinopatia hipertensiva maligna secundária a lúpus eritematoso sistêmico em adolescente. Revista Brasileira de Oftalmologia 2022;81:e0020. [DOI: 10.37039/1982.8551.20220020] [Reference Citation Analysis]
151 Katkam SK, Rajasekhar L, Kutala VK. The influence of functional polymorphic positions of HLA-DRβ1 molecules on risk for South Indian systemic lupus erythematosus patients. Lupus 2018;27:991-1000. [DOI: 10.1177/0961203318759200] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
152 Yin X, Kim K, Suetsugu H, Bang SY, Wen L, Koido M, Ha E, Liu L, Sakamoto Y, Jo S, Leng RX, Otomo N, Kwon YC, Sheng Y, Sugano N, Hwang MY, Li W, Mukai M, Yoon K, Cai M, Ishigaki K, Chung WT, Huang H, Takahashi D, Lee SS, Wang M, Karino K, Shim SC, Zheng X, Miyamura T, Kang YM, Ye D, Nakamura J, Suh CH, Tang Y, Motomura G, Park YB, Ding H, Kuroda T, Choe JY, Li C, Niiro H, Park Y, Shen C, Miyamoto T, Ahn GY, Fei W, Takeuchi T, Shin JM, Li K, Kawaguchi Y, Lee YK, Wang YF, Amano K, Park DJ, Yang W, Tada Y, Lau YL, Yamaji K, Zhu Z, Shimizu M, Atsumi T, Suzuki A, Sumida T, Okada Y, Matsuda K, Matsuo K, Kochi Y, Yamamoto K, Ohmura K, Kim TH, Yang S, Yamamoto T, Kim BJ, Shen N, Ikegawa S, Lee HS, Zhang X, Terao C, Cui Y, Bae SC; Japanese Research Committee on Idiopathic Osteonecrosis of the Femoral Head. Biological insights into systemic lupus erythematosus through an immune cell-specific transcriptome-wide association study. Ann Rheum Dis 2022:annrheumdis-2022-222345. [PMID: 35609976 DOI: 10.1136/annrheumdis-2022-222345] [Reference Citation Analysis]
153 Bragazzi NL, Watad A, Damiani G, Adawi M, Amital H, Shoenfeld Y. Role of anti-DNA auto-antibodies as biomarkers of response to treatment in systemic lupus erythematosus patients: hypes and hopes. Insights and implications from a comprehensive review of the literature. Expert Rev Mol Diagn 2019;19:969-78. [PMID: 31516059 DOI: 10.1080/14737159.2019.1665511] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
154 Yang F, Zhai Z, Luo X, Luo G, Zhuang L, Zhang Y, Li Y, Sun E, He Y. Bioinformatics identification of key candidate genes and pathways associated with systemic lupus erythematosus. Clin Rheumatol 2020;39:425-34. [PMID: 31673979 DOI: 10.1007/s10067-019-04751-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
155 Sano E, Arawaka S. White Matter Hyperintensities as a Risk Factor for Ischemic Stroke in Patients With Systemic Lupus Erythematosus. Front Neurol 2021;12:738173. [PMID: 34970201 DOI: 10.3389/fneur.2021.738173] [Reference Citation Analysis]
156 van der Heijde D, Daikh DI, Betteridge N, Burmester GR, Hassett AL, Matteson EL, van Vollenhoven R, Lakhanpal S. Common language description of the term rheumatic and musculoskeletal diseases (RMDs) for use in communication with the lay public, healthcare providers and other stakeholders endorsed by the European League Against Rheumatism (EULAR) and the American College of Rheumatology (ACR). Ann Rheum Dis 2018;77:829-32. [PMID: 29525777 DOI: 10.1136/annrheumdis-2017-212565] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
157 Kabeerdoss J, Danda D. Understanding immunopathological fallout of human coronavirus infections including COVID-19: Will they cross the path of rheumatologists? Int J Rheum Dis 2020;23:998-1008. [PMID: 32779341 DOI: 10.1111/1756-185X.13909] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
158 Hoge C, Bowling CB, Lim SS, Drenkard C, Plantinga LC. Association of Poverty Income Ratio with Physical Functioning in a Cohort of Patients with Systemic Lupus Erythematosus. J Rheumatol 2020;47:983-90. [PMID: 32115428 DOI: 10.3899/jrheum.190991] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
159 Ahmed AR, Anwar S, Reche PA. Molecular Basis for Global Incidence of Pemphigoid Diseases and Differences in Phenotypes. Front Immunol 2022;13:807173. [DOI: 10.3389/fimmu.2022.807173] [Reference Citation Analysis]
160 Lillis TA, Tirone V, Gandhi N, Weinberg S, Nika A, Sequeira W, Hobfoll SE, Block JA, Jolly M. Sleep Disturbance and Depression Symptoms Mediate Relationship Between Pain and Cognitive Dysfunction in Lupus. Arthritis Care Res (Hoboken) 2019;71:406-12. [PMID: 29726637 DOI: 10.1002/acr.23593] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
161 Ni J, Zhu H, Lu L, Zhao Z, Jiang J, You X, Wang Y, Ma Y, Yang Z, Hou Y, Dou H. Hydroxychloroquine induces apoptosis of myeloid-derived suppressor cells via up-regulation of CD81 contributing to alleviate lupus symptoms. Mol Med 2022;28:65. [PMID: 35705919 DOI: 10.1186/s10020-022-00493-6] [Reference Citation Analysis]
162 Tanaka Y, Tummala R. Anifrolumab, a monoclonal antibody to the type I interferon receptor subunit 1, for the treatment of systemic lupus erythematosus: an overview from clinical trials. Mod Rheumatol 2021;31:1-12. [PMID: 32814461 DOI: 10.1080/14397595.2020.1812201] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
163 Guo X, Yang X, Li Q, Shen X, Zhong H, Yang Y. The Microbiota in Systemic Lupus Erythematosus: An Update on the Potential Function of Probiotics. Front Pharmacol 2021;12:759095. [PMID: 34887760 DOI: 10.3389/fphar.2021.759095] [Reference Citation Analysis]
164 Martínez T, Garcia-Robledo JE, Plata I, Urbano MA, Posso-Osorio I, Rios-Serna LJ, Barrera MC, Tobón GJ. Mechanisms of action and historical facts on the use of intravenous immunoglobulins in systemic lupus erythematosus. Autoimmun Rev 2019;18:279-86. [PMID: 30639648 DOI: 10.1016/j.autrev.2018.10.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
165 Barber MRW, Clarke AE. Socioeconomic consequences of systemic lupus erythematosus. Curr Opin Rheumatol 2017;29:480-5. [PMID: 28520683 DOI: 10.1097/BOR.0000000000000416] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
166 Zhang C, Zhang C, Ji J, Xiong X, Lu Y. Hsa_circ_0012919 regulates expression of MDA5 by miR-125a-3p in CD4+ T cells of systemic lupus erythematous. Lupus 2020;29:727-34. [PMID: 32321346 DOI: 10.1177/0961203320920706] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
167 Parodis I, Lopez Benavides AH, Zickert A, Pettersson S, Möller S, Welin Henriksson E, Voss A, Gunnarsson I. The Impact of Belimumab and Rituximab on Health-Related Quality of Life in Patients With Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken) 2019;71:811-21. [PMID: 30055091 DOI: 10.1002/acr.23718] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 7.5] [Reference Citation Analysis]
168 Radmanesh F, Mahmoudi M, Yazdanpanah E, Keyvani V, Kia N, Nikpoor AR, Zafari P, Esmaeili SA. The immunomodulatory effects of mesenchymal stromal cell-based therapy in human and animal models of systemic lupus erythematosus. IUBMB Life 2020;72:2366-81. [PMID: 33006813 DOI: 10.1002/iub.2387] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
169 Xu Y, Xu JW, Wang YJ, Tung TH, Chien CW. Belimumab combined with standard therapy does not increase adverse effects compared with a control treatment: A systematic review and meta-analysis of randomised controlled trials. Int Immunopharmacol 2022;109:108811. [PMID: 35512563 DOI: 10.1016/j.intimp.2022.108811] [Reference Citation Analysis]
170 Murimi-Worstell IB, Lin DH, Nab H, Kan HJ, Onasanya O, Tierce JC, Wang X, Desta B, Alexander GC, Hammond ER. Association between organ damage and mortality in systemic lupus erythematosus: a systematic review and meta-analysis. BMJ Open 2020;10:e031850. [PMID: 32444429 DOI: 10.1136/bmjopen-2019-031850] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
171 Zhang R, Pan B, Li Y, Li X. SNP rs4937333 in the miRNA-5003-Binding Site of the ETS1 3'-UTR Decreases ETS1 Expression. Front Genet 2019;10:581. [PMID: 31275358 DOI: 10.3389/fgene.2019.00581] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
172 Cunningham NR, Fussner LM, Moorman E, Avar Aydin PO, Brunner HI, Kashikar-Zuck S. Development and pilot testing of the treatment and education approach for childhood-onset lupus (TEACH): a cognitive behavioral treatment. Pediatr Rheumatol Online J 2019;17:9. [PMID: 30777090 DOI: 10.1186/s12969-019-0307-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
173 Boesen EI, Kakalij RM. Autoimmune-mediated renal disease and hypertension. Clin Sci (Lond) 2021;135:2165-96. [PMID: 34533582 DOI: 10.1042/CS20200955] [Reference Citation Analysis]
174 Yu R, Jin G, Fujimoto M. Dihydroartemisinin: A Potential Drug for the Treatment of Malignancies and Inflammatory Diseases. Front Oncol 2021;11:722331. [PMID: 34692496 DOI: 10.3389/fonc.2021.722331] [Reference Citation Analysis]
175 Bratu IF, Ribigan AC, Mihailă-Bâldea S, Badea R, Stefan D, Davidoiu C, Casaru B, Antochi F. Febrile episode unmasking neuropsychiatric systemic lupus erythematosus with lytic lesions caused by secondary autoimmune myelofibrosis: Case report. Medicine (Baltimore) 2021;100:e28251. [PMID: 34941099 DOI: 10.1097/MD.0000000000028251] [Reference Citation Analysis]